EcoDrugPlus

Ensembl ID : WBGene00233931
Gene Symbol: WBGENE00233931
6 External references
75 Possible Orthologues:

Ensembl ID : WBGene00233932
Gene Symbol: WBGENE00233932
6 External references
110 Possible Orthologues:

Ensembl ID : WBGene00233933
Gene Symbol: WBGENE00233933
6 External references
73 Possible Orthologues:

Ensembl ID : WBGene00233934
Gene Symbol: WBGENE00233934
6 External references
74 Possible Orthologues:

Ensembl ID : WBGene00233937
Gene Symbol: WBGENE00233937
6 External references
75 Possible Orthologues:

Ensembl ID : WBGene00233938
Gene Symbol: WBGENE00233938
6 External references
74 Possible Orthologues:

Ensembl ID : WBGene00233971
Gene Symbol: WBGENE00233971
4 External references
68 Possible Orthologues:

Ensembl ID : WBGene00233979
Gene Symbol: WBGENE00233979
5 External references
201 Possible Orthologues:

Ensembl ID : WBGene00233980
Gene Symbol: WBGENE00233980
6 External references
121 Possible Orthologues:

Ensembl ID : WBGene00233982
Gene Symbol: WBGENE00233982
6 External references
108 Possible Orthologues:

Ensembl ID : WBGene00233999
Gene Symbol: WBGENE00233999
6 External references
64 Possible Orthologues:

Ensembl ID : WBGene00234001
Gene Symbol: WBGENE00234001
4 External references
156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).